Vinorelbine Injection, Solution
Product Images NDC 25021-204

3 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vinorelbine (NDC 25021-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Vin00 0007 01

Vin00 0007 01
Chemical structure diagram of the active ingredient Vinorelbine, showing the detailed molecular arrangement including functional groups and bonds, as well as the presence of two associated molecules indicated on the right side of the structure.*
FDA Label Image

Vin00 0007 02

Vin00 0007 02
A survival rate graph comparing two intravenous treatments, IV CDDP alone and IV CDDP combined with Vinorelbine. The x-axis represents months after registration, spanning 0 to 30 months, and the y-axis shows survival rate percentage from 0% to 100%. The graph includes median survival values and risk data for each treatment group.*
FDA Label Image

Vin00 0007 03

Vin00 0007 03
Label for Vinorelbine Injection, USP 10 mg per mL in a 1 mL single-dose vial. The label indicates it must be diluted and is for intravenous use only. It is sterile, nonpyrogenic, and preservative-free. Manufactured by Sagent Pharmaceuticals, Inc., the label includes storage instructions to refrigerate and protect from light and freeze, and a caution that it is a cytotoxic agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.